BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8405375)

  • 1. Participation of cathepsin B in processing of antigen presentation to MHC class II.
    Matsunaga Y; Saibara T; Kido H; Katunuma N
    FEBS Lett; 1993 Jun; 324(3):325-30. PubMed ID: 8405375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.
    Deussing J; Roth W; Saftig P; Peters C; Ploegh HL; Villadangos JA
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4516-21. PubMed ID: 9539769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B S-nitrosylation promotes ADAR1-mediated editing of its own mRNA transcript via an ADD1/MATR3 regulatory axis.
    Lin Z; Zhao S; Li X; Miao Z; Cao J; Chen Y; Shi Z; Zhang J; Wang D; Chen S; Wang L; Gu A; Chen F; Yang T; Sun K; Han Y; Xie L; Chen H; Ji Y
    Cell Res; 2023 Jul; 33(7):546-561. PubMed ID: 37156877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 Receptor Triggers Lysosomal Leakage Through Calcium Mobilization in a Mechanism Dependent on Pannexin-1 Hemichannels.
    Santos SACS; Persechini PM; Henriques-Santos BM; Bello-Santos VG; Castro NG; Costa de Sousa J; Genta FA; Santiago MF; Coutinho-Silva R; Savio LEB; Kurtenbach E
    Front Immunol; 2022; 13():752105. PubMed ID: 35222364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bibenzyls and bisbybenzyls of bryophytic origin as promising source of novel therapeutics: pharmacology, synthesis and structure-activity.
    Nandy S; Dey A
    Daru; 2020 Dec; 28(2):701-734. PubMed ID: 32803687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of bovine mammary epithelial cells after in vitro incubation with S. agalactiae: potential biomarkers.
    Tong J; Sun M; Zhang H; Yang D; Zhang Y; Xiong B; Jiang L
    Vet Res; 2020 Aug; 51(1):98. PubMed ID: 32746898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21.
    Welsby I; Detienne S; N'Kuli F; Thomas S; Wouters S; Bechtold V; De Wit D; Gineste R; Reinheckel T; Elouahabi A; Courtoy PJ; Didierlaurent AM; Goriely S
    Front Immunol; 2016; 7():663. PubMed ID: 28105029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR peptide occupancy can be regulated with a wide variety of small molecules.
    Blazekovic F; Odukoya D; Butler SN; Mauro JA; Ramsamooj M; Puleo E; Szekeres K; Dana D; Kumar S; Ragupathi G; Blanck G
    Hum Vaccin Immunother; 2016 Mar; 12(3):593-8. PubMed ID: 26453454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B regulates the appearance and severity of mercury-induced inflammation and autoimmunity.
    Toomey CB; Cauvi DM; Hamel JC; Ramirez AE; Pollard KM
    Toxicol Sci; 2014 Dec; 142(2):339-49. PubMed ID: 25237059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis.
    Johnson EM; Doyle JD; Wetzel JD; McClung RP; Katunuma N; Chappell JD; Washington MK; Dermody TS
    J Virol; 2009 Oct; 83(19):9630-40. PubMed ID: 19640986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-headed cathepsin B inhibitor devoid of warhead.
    Schenker P; Alfarano P; Kolb P; Caflisch A; Baici A
    Protein Sci; 2008 Dec; 17(12):2145-55. PubMed ID: 18796695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.
    Ramani K; Miclea RD; Purohit VS; Mager DE; Straubinger RM; Balu-Iyer SV
    J Pharm Sci; 2008 Apr; 97(4):1386-98. PubMed ID: 17705286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proteolysis of diphtheria toxin by human monocytes after heat shock: a subsidiary role for heat-shock protein 70 in antigen processing.
    Polla BS; Gabert F; Peyrusse BM; Jacquier-Sarlin MR
    Immunology; 2007 Feb; 120(2):230-41. PubMed ID: 17116171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?
    Buttle DJ; Bramwell H; Hollander AP
    Clin Mol Pathol; 1995 Aug; 48(4):M167-77. PubMed ID: 16696000
    [No Abstract]   [Full Text] [Related]  

  • 15. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
    Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
    J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.
    Peppard JV; Knap AK
    In Vitro Cell Dev Biol Anim; 1999 Sep; 35(8):459-64. PubMed ID: 10501085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases.
    Kerblat I; Drouet C; Chesne S; Marche PN
    Immunology; 1999 May; 97(1):62-8. PubMed ID: 10447715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway.
    Liversidge J; Dawson R; Dick AD; Forrester JV
    Immunology; 1998 Jun; 94(2):271-8. PubMed ID: 9741352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin S activity regulates antigen presentation and immunity.
    Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
    J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
    Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
    J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.